Skip to content
10-Q

Quarterly Report

NASCENT BIOTECH, INC.

0001477932-23-008227

← back to feed
Filed
Nov 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Nov 9, 2023 166.74M sh
Operating Cash Flow Q2 2024 · Sep 30, 2023 −$504.22K
Operating Cash Flow Q2 2024 · Sep 30, 2022 −$777.5K
Stockholders Equity Q2 2024 · Sep 30, 2023 −$6.41K
Stockholders Equity Q2 2024 · Jun 30, 2023 −$1.12M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$1.3M
Stockholders Equity Q2 2024 · Sep 30, 2022 −$1.19M
Stockholders Equity Q2 2024 · Jun 30, 2022 −$1.44M
Stockholders Equity Q2 2024 · Mar 31, 2022 −$671.48K
Current Liabilities Q2 2024 · Sep 30, 2023 $1.05M
Current Liabilities Q2 2024 · Mar 31, 2023 $1.55M
Total Liabilities Q2 2024 · Sep 30, 2023 $1.05M
Total Liabilities Q2 2024 · Mar 31, 2023 $1.55M
Current Assets Q2 2024 · Sep 30, 2023 $1.04M
Current Assets Q2 2024 · Mar 31, 2023 $255K
Total Assets Q2 2024 · Sep 30, 2023 $1.04M
Total Assets Q2 2024 · Mar 31, 2023 $255K
Rd Expense Q2 2024 · Sep 30, 2023 $28.31K
Rd Expense Q2 2024 · Sep 30, 2023 $54.22K
Rd Expense Q2 2024 · Sep 30, 2022 $75.74K
Rd Expense Q2 2024 · Sep 30, 2022 $132.63K
Net Income Q2 2024 · Sep 30, 2023 −$829.48K
Net Income Q2 2024 · Sep 30, 2023 −$1.37M
Net Income Q2 2024 · Jun 30, 2023 −$540.22K
Net Income Q2 2024 · Sep 30, 2022 −$145.71K
Net Income Q2 2024 · Sep 30, 2022 −$1.45M
Net Income Q2 2024 · Jun 30, 2022 −$1.3M
Operating Income Q2 2024 · Sep 30, 2023 −$837.46K
Operating Income Q2 2024 · Sep 30, 2023 −$1.35M
Operating Income Q2 2024 · Sep 30, 2022 −$521.23K
Operating Income Q2 2024 · Sep 30, 2022 −$1.14M